Friday, May 26th 2017

08:30-09:00 am Delivery of documentation
09:00-09:15 am Opening
09:15-10:00 am Measuring cognitive changes in HIV infection: Size really matters. José A. Muñoz-Moreno. Lluita contra la SIDA Foundation, Spain
10:00-10:45 am Pros and Cos of antiretroviral treatment on CNS. Ignacio Pérez-Valero. Hospital Universitario. La Paz. Madrid. Spain.
10:45-11:30 pm Coffee Break & Poster Session – 1
11:30-12:30 pm Oral Communications Session – 1

  1. Prevalence of psychiatric comorbidities among VIH-infected patients. Natalia Gil.
  2. Communication of the diagnosis of HIV infection: patients’ experiences and preferences. Isabel Ramos.
  3. Overall and CNS safety of integrase inhibitors. Josep Maria Llibre.
12:30-01:00 pm Integrase inhibitors and the brain. Alan Winston. St. Mary’s Hospital. London, United Kingdom.
01:00-02:00 pm Lunchtime
02:00-02:45 pm Neurological soft signs in HIV associated neurocognitive disorder (HAND): an easy clinical examination for screening and early recognition. Johannes Shröder. Institute of Gerontology, University Hospital of Heidelberg. Germany
02:45-03:30 pm Pharmacokinetic issues and CNS in HIV-infected patients. Andrea Calcagno. University of Torino, Italy
03:30-07:00 pm Workshop. Practical training on diagnosis and management of clinical CNS problems in HIV-infected patients (Diagnosis and treatment of psychiatric and medical clinical situations)
a) Diagnosis and screening of neurocognitive impairment in HIV-infected patients.
b) Prevention and treatment of neurocognitive impairment in HIV-infected patients.

Gabriele Arendt; Andrea Calcagno; Paola Cinque; Ignacio Pérez-Valero; Alan Winston; Esteban Martínez.
c) Diagnosis and screening of psychiatric conditions in HIV-infected patients.
d) Prevention and treatment of psychiatric conditions in HIV-infected patients.

Guida da Ponte; Maria Ferrara; Scott Letendre; Lawrence McGlynn; José A. Muñoz-Moreno; Jordi Blanch.

Saturday, May 27th 2017

08:30-10:00 am Risk behavior, effect on HIV-infection and neuropsychiatric consequences of substance use.
María Martínez-Rebollar
. Hospital Clínic. Barcelona. Spain.
Percy Fernández. Universidad Educación a Distancia. Spain.
Lawrence McGlynn. Standford Medical School. San Francisco. USA.
10:00-10:45 am Oral Communications. Session 2

  1. Neurocognitive disorders in patients with HIV infection with virological suppression > 10 years. Isabel Ramos.
  2. New Advanced EEG Technique (LORETA – Low Resolution Electromagnetic Tomography) to Early Detect and Monitor HIV Brain Damage. Elisabetta Teti.
  3. What do psychiatrists need to know when treating HAND – Differential Diagnosis and HAART neurotoxicity. Guida Da Ponte.
  4. Transdermal Rivastigmine for HIV-Associated Cognitive Impairment: Preliminary Results from a Randomized. José A. Muñoz-Moreno.
10:45-11:30 am Coffee Break & Poster Session – 2
11:30-12:15 pm Hot topics on CNS and HIV (most relevant presentations in conferences or articles published recently). Paola Cinque. Hospital San Rafael. Milano. Italy.
12:15-01:15 pm Summary of the Symposium and discussion. Scott Letendre. University of California. San Diego. USA.
01:15-01:30 pm Closure and Farewell


Download Programme PDF